OxySure (OXYS) Announces $1.575 Million Institutional Financing
Frisco, Texas, January 6, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company has signed agreements for $1.575 million in equity financing with an existing accredited, institutional investor. Pursuant to the private placement financing, the Company increased the number of shares designated as the Company’s Series B Convertible Preferred Stock (“Series B Preferred”), from 750 shares to 3,500 shares, with a stated